TY - JOUR
T1 - A multicenter application and evaluation of the oxford classification of iga nephropathy in adult Chinese patients
AU - Zeng, Cai Hong
AU - Le, Weibo
AU - Ni, Zhaohui
AU - Zhang, Minfang
AU - Miao, Lining
AU - Luo, Ping
AU - Wang, Rong
AU - Lv, Zhimei
AU - Chen, Jianghua
AU - Tian, Jiong
AU - Chen, Nan
AU - Pan, Xiaoxia
AU - Fu, Ping
AU - Hu, Zhangxue
AU - Wang, Lining
AU - Fan, Qiuling
AU - Zheng, Hongguang
AU - Zhang, Dewei
AU - Wang, Yaping
AU - Huo, Yanhong
AU - Lin, Hongli
AU - Chen, Shuni
AU - Sun, Shiren
AU - Wang, Yanxia
AU - Liu, Zhangsuo
AU - Liu, Dong
AU - Ma, Lu
AU - Pan, Tao
AU - Zhang, Aiping
AU - Jiang, Xiaoyu
AU - Xing, Changying
AU - Sun, Bing
AU - Zhou, Qiaoling
AU - Tang, Wenbing
AU - Liu, Fuyou
AU - Liu, Yinghong
AU - Liang, Shaoshan
AU - Xu, Feng
AU - Huang, Qian
AU - Shen, Hongbing
AU - Wang, Jianming
AU - Shyr, Yu
AU - Phillips, Sharon
AU - Trojanov, Stéphan
AU - Fogo, Agnes
AU - Liu, Zhi Hong
N1 - Funding Information:
Support: The authors acknowledge support from the National Natural Science Foundation of China ( 810-2010-8016 ) and the National Basic Research Program of China 973 program no. 2012CB517600 (no. 2012CB517606).
PY - 2012/11
Y1 - 2012/11
N2 - Background: The Oxford classification of immunoglobulin A (IgA) nephropathy (IgAN) provides a histopathologic grading system that is associated with kidney disease outcomes independent of clinical features. We evaluated the Oxford IgAN classification in a large cohort of patients from China. Study Design: Retrospective study. Setting & Participants: 1,026 adults with IgAN from 18 referral centers in China. Inclusion criteria and statistical analysis were similar to the Oxford study. Predictors: Histologic findings of mesangial hypercellularity score, endocapillary proliferation, segmental sclerosis or adhesion, crescents, necrosis, and tubular atrophy/interstitial fibrosis. Clinical features, blood pressure, estimated glomerular filtration rate (eGFR), proteinuria, and treatment modalities. Outcomes: Time to a 50% reduction in eGFR or end-stage renal disease (the combined event); the rate of eGFR decline (slope of eGFR); proteinuria during follow-up. Results: Compared with the Oxford cohort, the Chinese cohort had a lower proportion of patients with mesangial hypercellularity (43%) and endocapillary proliferation (11%), higher proportion with segmental sclerosis or adhesion (83%) and necrosis (15%), and similar proportion with crescents (48%) and tubular atrophy/interstitial fibrosis (moderate, 24%; severe, 3.3%). During a median follow-up of 53 (25th-75th percentile, 36-67) months, 159 (15.5%) patients reached the combined event. Our study showed that patients with a mesangial hypercellularity score higher than 0.5 were associated with a 2.0-fold (95% CI, 1.5-2.8; P<0.001) higher risk of the combined event than patients with a score of 0.5 or lower. Patients with tubular atrophy/interstitial fibrosis of 25%-50% and >50% versus <25% were associated with a 3.7-fold (95% CI, 2.6-5.1; P<0.001) and 15.1-fold (95% CI, 9.5-24.2; P<0.001) higher risk of the combined event, respectively. Endocapillary proliferation, glomerular crescents, and necrosis were not significant. Limitations: Retrospective study; the therapeutic interventions were miscellaneous. Conclusions: We confirmed the associations of mesangial hypercellularity and tubular atrophy/interstitial fibrosis with kidney disease outcomes.
AB - Background: The Oxford classification of immunoglobulin A (IgA) nephropathy (IgAN) provides a histopathologic grading system that is associated with kidney disease outcomes independent of clinical features. We evaluated the Oxford IgAN classification in a large cohort of patients from China. Study Design: Retrospective study. Setting & Participants: 1,026 adults with IgAN from 18 referral centers in China. Inclusion criteria and statistical analysis were similar to the Oxford study. Predictors: Histologic findings of mesangial hypercellularity score, endocapillary proliferation, segmental sclerosis or adhesion, crescents, necrosis, and tubular atrophy/interstitial fibrosis. Clinical features, blood pressure, estimated glomerular filtration rate (eGFR), proteinuria, and treatment modalities. Outcomes: Time to a 50% reduction in eGFR or end-stage renal disease (the combined event); the rate of eGFR decline (slope of eGFR); proteinuria during follow-up. Results: Compared with the Oxford cohort, the Chinese cohort had a lower proportion of patients with mesangial hypercellularity (43%) and endocapillary proliferation (11%), higher proportion with segmental sclerosis or adhesion (83%) and necrosis (15%), and similar proportion with crescents (48%) and tubular atrophy/interstitial fibrosis (moderate, 24%; severe, 3.3%). During a median follow-up of 53 (25th-75th percentile, 36-67) months, 159 (15.5%) patients reached the combined event. Our study showed that patients with a mesangial hypercellularity score higher than 0.5 were associated with a 2.0-fold (95% CI, 1.5-2.8; P<0.001) higher risk of the combined event than patients with a score of 0.5 or lower. Patients with tubular atrophy/interstitial fibrosis of 25%-50% and >50% versus <25% were associated with a 3.7-fold (95% CI, 2.6-5.1; P<0.001) and 15.1-fold (95% CI, 9.5-24.2; P<0.001) higher risk of the combined event, respectively. Endocapillary proliferation, glomerular crescents, and necrosis were not significant. Limitations: Retrospective study; the therapeutic interventions were miscellaneous. Conclusions: We confirmed the associations of mesangial hypercellularity and tubular atrophy/interstitial fibrosis with kidney disease outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84867577763&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84867577763&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2012.06.011
DO - 10.1053/j.ajkd.2012.06.011
M3 - Article
C2 - 22819700
AN - SCOPUS:84867577763
SN - 0272-6386
VL - 60
SP - 812
EP - 820
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 5
ER -